An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19)

Since 2019, COVID-19 has become the most important health dilemma around the world. The dysregulated immune response which results in ARDS and cytokine storm has an outstanding role in the progression of pulmonary damage in COVID-19. IL-6, through induction of pro-inflammatory chemokines and cytokin...

Descripción completa

Detalles Bibliográficos
Autores principales: Elahi, Reza, Karami, Parsa, Heidary, Amir Hossein, Esmaeilzadeh, Abdolreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747952/
https://www.ncbi.nlm.nih.gov/pubmed/35074571
http://dx.doi.org/10.1016/j.intimp.2022.108536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747952/
https://www.ncbi.nlm.nih.gov/pubmed/35074571
http://dx.doi.org/10.1016/j.intimp.2022.108536

Ejemplares similares